You are here

Home » CERID Bibliography

CERID Bibliography

Export 120 results:
Author Title [ Type(Desc)] Year
Filters: Author is Gale, Michael  [Clear All Filters]
Journal Article
Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M, Virgin HW, Klein RS, Sen GC, Diamond MS. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012 ;8(5):e1002698.
Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin T-Y, Schneller S, Zust R, Dong H, et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010 ;468(7322):452-6.
Lanford RE, Evans MJ, Lohmann V, Lindenbach B, Gale M, Rehermann B, Chang K-M, Lemon SM. The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses. Gastroenterology. 2009 ;136(1):9-16.
Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, Chen ZJ, Gale M. Activation of the interferon-beta promoter during hepatitis C virus RNA replication. Viral Immunol. 2002 ;15(1):29-40.
Wang C, Pflugheber J, Sumpter R, Sodora DL, Hui D, Sen GC, Gale M. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol. 2003 ;77(7):3898-912.
Erickson AK, Seiwert S, Gale M. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. Antivir Ther. 2008 ;13(7):851-62.
Owen DM, Huang H, Ye J, Gale M. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology. 2009 ;394(1):99-108.
Wollish AC, Ferris MT, Blevins LK, Loo Y-M, Gale M, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology. 2013 ;435(2):269-80.
Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M, Barber GN, Stetson DB. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012 ;36(1):120-31.
Lazear HM, Pinto AK, Vogt MR, Gale M, Diamond MS. Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol. 2011 ;85(14):7186-94.
Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, Gale M, J Farrar D. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol. 2008 ;180(10):6923-32.
Johnson CL, Gale M. CARD games between virus and host get a new player. Trends Immunol. 2006 ;27(1):1-4.
Ma DY, Suthar MS, Kasahara S, Gale M, Clark EA. CD22 is required for protection against West Nile virus Infection. J Virol. 2013 ;87(6):3361-75.
Diamond MS, Gale M. Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol. 2012 ;33(10):522-30.
Daffis S, Samuel MA, Keller BC, Gale M, Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007 ;3(7):e106.
Luke JM, Simon GG, Söderholm J, Errett JS, J August T, Gale M, Hodgson CP, Williams JA. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol. 2011 ;85(3):1370-83.
Foy E, Li K, Sumpter R, Loo Y-M, Johnson CL, Wang C, Fish PMar, Yoneyama M, Fujita T, Lemon SM, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A. 2005 ;102(8):2986-91.
Horner SM, Park HSoo, Gale M. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol. 2012 ;86(6):3112-20.
Patel MR, Loo Y-M, Horner SM, Gale M, Malik HS. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol. 2012 ;10(3):e1001282.
Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013 ;19(4):458-64.
Saito T, Gale M. Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J Exp Med. 2008 ;205(7):1523-7.
Ye J, Wang C, Sumpter R, Brown MS, Goldstein JL, Gale M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A. 2003 ;100(26):15865-70.
Li K, Chen Z, Kato N, Gale M, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005 ;280(17):16739-47.
Loo Y-M, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008 ;82(1):335-45.
Benecke A, Gale M, Katze MG. Dynamics of innate immunity are key to chronic immune activation in AIDS. Curr Opin HIV AIDS. 2012 ;7(1):79-85.

Pages